| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurological Sciences (Drs. Bulgakova, Leurgans, Bennett, Fleischman, and deToledo-Morrell, T.R. Stoub), Diagnostic Radiology and Nuclear Medicine (Dr. Turner), Psychology (Dr. deToledo-Morrell), and Preventive Medicine (Dr. Leurgans) and Rush Alzheimer’s Disease Center (Drs. Bennett and Fleischman), Rush University Medical Center, Chicago, IL.
Address correspondence and reprint requests to Dr. L. deToledo-Morrell, Department of Neurologic Sciences, Rush University, 1653 W. Congress Pkwy., Chicago, IL 60612; e-mail: ldetoled{at}rush.edu
Objective: To determine if baseline entorhinal and hippocampal volumes and their rate of atrophy could predict the risk of incident Alzheimer disease (AD).
Methods: The authors used proportional odds models to assess the relationship between entorhinal and hippocampal size and risk of incident AD among 58 nondemented elderly people. All participants were followed with annual clinical evaluations and structural MRI scans for up to 5 years (baseline and 5 years of follow-up). At baseline, 23 of 58 participants received a diagnosis of amnestic mild cognitive impairment (MCI) and 35 of 58 were healthy control subjects with no cognitive impairment. Structural MRI scans were acquired with a T1-weighted three-dimensional spoiled gradient-recalled echo pulse sequence in a 1.5 T scanner. Entorhinal and hippocampal volumes were derived from 1.6-mm gapless coronal images reformatted to be perpendicular to the long axis of the hippocampus and were normalized by dividing with intracranial volume.
Results: Fourteen of 58 nondemented participants developed AD during the follow-up period. Initial diagnosis of MCI was a significant predictor of incident AD. In addition, both baseline entorhinal volume and its slope of decline were independent predictors of incident AD, but initial hippocampal size and its rate of decline were not, after controlling for entorhinal volume.
Conclusion: In nondemented individuals, entorhinal cortex atrophy is associated with risk of Alzheimer disease.
Supported by grants P01 AG09466, P30 AG10161, and R01 AG17917 from the National Institute on Aging, NIH. T.R.S. received support from a predoctoral training grant (T32 AG00269) from the National Institute on Aging.
Dr. Bulgakova’s current address is Division of Neurobiology, Barrow Neurological Institute, Phoenix, AZ.
Received July 7, 2004. Accepted in final form January 7, 2005.
This article has been cited by other articles:
|
|
 |
|
  A J Mitchell and M Shiri-Feshki Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis J. Neurol. Neurosurg. Psychiatry, December 1, 2008; 79(12): 1386 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J B Williamson, D L Nyenhuis, L Pedelty, S Byrd, M Jhaveri, C Wang, L deToledo-Morrell, K Sripathirathan, and P Gorelick Baseline differences between vascular cognitive impairment no dementia reverters and non-reverters J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1208 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Brickman, L. S. Honig, N. Scarmeas, O. Tatarina, L. Sanders, M. S. Albert, J. Brandt, D. Blacker, and Y. Stern Measuring Cerebral Atrophy and White Matter Hyperintensity Burden to Predict the Rate of Cognitive Decline in Alzheimer Disease Arch Neurol, September 1, 2008; 65(9): 1202 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Liu, Z. You, J. Ren, Y. R. Kim, K. Eikermann-Haerter, and P. K. Liu Noninvasive delivery of gene targeting probes to live brains for transcription MRI FASEB J, April 1, 2008; 22(4): 1193 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Fleisher, S. Sun, C. Taylor, C. P. Ward, A. C. Gamst, R. C. Petersen, C. R. Jack Jr, P. S. Aisen, L. J. Thal, and For the Alzheimer's Disease Cooperative Study Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment Neurology, January 15, 2008; 70(3): 191 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Whitwell, S. A. Przybelski, S. D. Weigand, D. S. Knopman, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease Brain, July 1, 2007; 130(7): 1777 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Devanand, G. Pradhaban, X. Liu, A. Khandji, S. De Santi, S. Segal, H. Rusinek, G. H. Pelton, L. S. Honig, R. Mayeux, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease Neurology, March 13, 2007; 68(11): 828 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Small, V. Kepe, L. M. Ercoli, P. Siddarth, S. Y. Bookheimer, K. J. Miller, H. Lavretsky, A. C. Burggren, G. M. Cole, H. V. Vinters, et al. PET of Brain Amyloid and Tau in Mild Cognitive Impairment N. Engl. J. Med., December 21, 2006; 355(25): 2652 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Singh, H. Chertkow, J. P. Lerch, A. C. Evans, A. E. Dorr, and N. J. Kabani Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease Brain, November 1, 2006; 129(11): 2885 - 2893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Stoub, L. deToledo-Morrell, G. T. Stebbins, S. Leurgans, D. A. Bennett, and R. C. Shah Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease PNAS, June 27, 2006; 103(26): 10041 - 10045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Other articles noted Evid. Based Med., December 1, 2005; 10(6): 191 - 192. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
